{"id":"W2898517298","doi":"10.1093/annonc/mdy424.074","title":"Health-related quality of life (HRQoL) for pembrolizumab or placebo plus carboplatin and paclitaxel or nab-paclitaxel in patients with metastatic squamous NSCLC: Data from KEYNOTE-407","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Humber River Regional Hospital","funders":"Merck Sharp and Dohme; Merck","keywords":"Medicine; Carboplatin; Paclitaxel; Placebo; Clinical endpoint; Pembrolizumab; Internal medicine; Tolerability; Quality of life (healthcare); Oncology; Clinical trial; Chemotherapy; Cancer; Adverse effect; Nursing; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002472572,0.0006103884,0.001420233,0.0003821758,0.0002121512,0.0006141783,0.000564509,0.0006081084,0.00249661],"category_scores_gemma":[0.001805225,0.000272515,0.002781086,0.0007785343,0.0003165839,0.0008196906,0.0005023053,0.001633006,0.0003961475],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006756792,"about_ca_system_score_gemma":0.0006267883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001778569,"about_ca_topic_score_gemma":0.003834924,"domain_scores_codex":[0.9992403,0.0003031638,0.00009653357,0.0001257936,0.0001213463,0.0001129675],"domain_scores_gemma":[0.9989049,0.0003879832,0.0003556747,0.00007782386,0.00007322885,0.0002003508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8125804,0.003397705,0.09327768,0.002007152,0.01185056,0.0001375923,0.0001374448,0.002322266,0.006443244,0.000157456,0.006126437,0.06156214],"study_design_scores_gemma":[0.2060998,0.09172555,0.6778773,0.0003182704,0.01140875,0.0003017205,0.000176655,0.001403789,0.002764962,0.0002921482,0.007526932,0.0001042213],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9683464,0.01239828,0.0003527325,0.0004613658,0.0001085034,0.000459317,0.01426333,0.00004508642,0.003565132],"genre_scores_gemma":[0.9791855,0.003330864,0.0005219789,0.0005281782,0.0001073707,0.0005220539,0.01450331,0.00001382226,0.001286761],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00249661,"threshold_uncertainty_score":0.01307642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2000696257598447,"score_gpt":0.4352044458391081,"score_spread":0.2351348200792635,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}